Medical device company LeMaitre Vascular will announce its earnings results this Tuesday after market close. The market expects revenue to grow 11.5% year on year, a slowdown from the 15% increase recorded in the same quarter last year. Analysts have generally reconfirmed their estimates over the last 30 days, though the company has missed Wall Street revenue estimates multiple times over the past two years. LeMaitre shares are down 2.5% over the last month, heading into earnings with an average analyst price target of $118.75 compared to the current share price of $101.32.
LeMaitre Vascular IncEarnings report upcoming; expectations and past misses create uncertainty.